Pfizer RFP COVID-19 Competitive Grant Program

May 1, 2020, 15:17 PM by Melodi Moore

Pfizer Logo



During this challenging time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. We recognize the need for the rapid development of educational programs and trainings and the implementation of systemic best practices for COVID-19 management. As part of our commitment, we are releasing this Request for Proposals (RFP) to provide financial support for organizations producing independent educational programs and quality improvement initiatives designed to combat this evolving crisis.

This competitive grant program from Pfizer Global Medical Grants (GMG) involves a publicly posted RFP that provides details regarding a specific area of interest, sets timelines for review and approval, and uses an internal review process to make final grant decisions. For this RFP, organizations are invited to submit an application addressing the gaps in knowledge and practice of COVID-19 management as outlined in the RFP document.

Date RFP Issued: April 13, 2020

Geographic Scope: Global

Clinical Area:  COVID-19

Link to full RFP: COVID-19 Competitive Grant Program

Application Closing Date: May 22, 2020

To facilitate a rapid response, application reviews and approvals will be done on a rolling basis. Although the RFP application window is open for 6 weeks, organizations are encouraged to apply as soon as possible. We anticipate a high volume of applications and will continue to award grants until the budget is depleted.

Specific Area of Interest: Through this RFP, it is our intent to support educational programs for healthcare providers focused on the recognition, diagnosis, treatment, and overall care management of patients with COVID-19, as well as provide support to hospitals or healthcare systems so that they may evaluate and improve their systems-of-care for COVID-19 patients.

Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Derek Warnick (derek.warnick@pfizer.com).